FDA Authorizes Rapid, Affordable at-Home Testing for COVID-19
by Dr. C. H. Weaver M.D. 8/26/2020
A COVID-19 test that takes 15 minutes and can be run without lab equipment was just granted emergency use authorization by the FDA. The test will cost $5, and runs on a simple card that uses the same technology as a pregnancy test. (2)
The test, called BinaxNOW, is produced by the health care company Abbott. The company is also launching an app that syncs up with the tests, and gives people who test negative for the virus a “digital health pass” that they can display on their phone. CEO Robert Ford said in a statement that the combination of the test and the app offer a “comprehensive testing solution.”
The FDA previously authorized the first COVID-19 diagnostic test with an at home collection option. The kits will “initially be made available to health care workers and first responders and the kits will be available to consumers “in the coming weeks.” Samples can be collected and tested from a patient’s nose using the testing kit’s nasal swabs and saline. Once collected, patients can mail in their sample to LabCorp in an uninsulated package. According to the company’s website, a test result will cost $119. That price includes the kit, two-way overnight shipping, “physician services” and the test in LabCorp’s laboratory. (1)
More COVID-19 Information
- Understanding the Coronavirus Testing Conundrum
- Cancer Patients & COVID-19 - How to Reduce Your Risks
- Toxicities of Hydroxychloroquine
- COVID-19 and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- The Coronavirus and Inflammatory Arthritis
- TheArthritisConnection Newsletter Signup
Our FDA authorized COVID-19 kits provide everything you need to collect a nasal swab sample and send it back to our lab. Kits are available to all individuals who meet the screening criteria for COVID-19 testing.
Abbott's Fast, $5, 15-Minute, Easy-to-Use COVID-19 Antigen Test Receives FDA Emergency Use Authorization; Mobile App Displays Test Results to Help Our Return…
Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its BinaxNOW™ COVID-19 Ag Card rapid test for detection of...